Stock Events

Stock Events

AtaiBeckley 

$7.33
405
-$0.01-0.14% 16:13 Today

Statistics

Day High
7.35
Day Low
7.31
52W High
7.45
52W Low
3.27
Volume
4,096,254
Avg. Volume
12,276,679
Mkt Cap
2.72B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.28
-0.21
-0.15
-0.08
Expected EPS
-0.123184
Actual EPS
N/A

Financials

-16,142.02%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.09MRevenue
-660.05MNet Income

Analyst Ratings

9.40Average Price Target
The highest estimate is 16.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
13%
Hold
88%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATAI. It's not an investment recommendation.
Amazon
50
AMZN
Apple
42
AAPL
NVIDIA
42
NVDA
Microsoft
41
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.9B
Compass Pathways operates in the psychedelic medicine space, directly competing with ATAI in developing therapies for mental health conditions.
GH Research
GHRS
Mkt Cap1.92B
GH Research is involved in the development of therapeutics for psychiatric and neurological disorders, overlapping with ATAI's mission and market.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness operates in the space of psychedelic therapy development, making it a competitor to ATAI in the mental health treatment sector.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics focuses on the research and development of psychedelic and cannabinoid-based therapeutics, competing with ATAI in the broader alternative medicine market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, has developed a ketamine-based nasal spray for depression, indirectly competing with ATAI's broader focus on mental health treatments.

About

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Show more...
CEO
Srinivas G. Rao
Employees
99
Country
United States
ISIN
US04650F1012
WKN
000A41WEP

Listings

STU
DE
B72.STU
MU
DE
B72.MU
MU
DE
9VC.MU
XNAS
US
ATAI

0 Comments

Share your thoughts

FAQ

What is AtaiBeckley stock price today?▼
The current price of ATAI is $7.33 USD — it has decreased by -0.14% in the past 24 hours. Watch AtaiBeckley stock price performance more closely on the chart.
What is AtaiBeckley stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange AtaiBeckley stocks are traded under the ticker ATAI.
Is AtaiBeckley stock price growing?▼
ATAI stock has risen by +0.48% compared to the previous week, the month change is a +2.02% rise, over the last year AtaiBeckley has showed a +60.64% increase.
What is AtaiBeckley market cap?▼
Today AtaiBeckley has the market capitalization of 2.72B
When is the next AtaiBeckley earnings date?▼
AtaiBeckley is going to release the next earnings report on November 12, 2026.
What were AtaiBeckley earnings last quarter?▼
ATAI earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.11 USD resulting in a +15.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AtaiBeckley revenue for the last year?▼
AtaiBeckley revenue for the last year amounts to 4.09M USD.
What is AtaiBeckley net income for the last year?▼
ATAI net income for the last year is -660.05M USD.
How many employees does AtaiBeckley have?▼
As of September 04, 2026, the company has 99 employees.
In which sector is AtaiBeckley located?▼
AtaiBeckley operates in the Health & Wellness sector.
When did AtaiBeckley complete a stock split?▼
AtaiBeckley has not had any recent stock splits.
Where is AtaiBeckley headquartered?▼
AtaiBeckley is headquartered in NEW YORK, United States.